Liquid Biopsy Analysis Shows MAGI2 Gene as Potential Negative Prognosis Biomarker in NSCLC Patients

Liquid Biopsy Analysis Shows MAGI2 Gene as Potential Negative Prognosis Biomarker in NSCLC Patients

Saved in:

Bibliographic Details
Main Authors:	P. Mediavilla, R. Serna Blasco, L. Robado de Lope, S. Sanz Moreno, A. Rodriguez Festa, P. Gallego Gil, C. Flores, M. Provencio, A. Romero
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	The Journal of Liquid Biopsy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2950195423000425
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

KRAS Mutations, Potential Biomarkers for the Identification of Non-small-Cell Lung Cancer Patients That May Benefit From Immunotherapy-Based Treatments
by: L. Robado De Lope, et al.
Published: (2023-11-01)

Mutational Prognosis of Survival by Liquid Biopsy in Advanced EGFRm NSCLC
by: M. Galvez-Nino, et al.
Published: (2023-11-01)

Genomic Profiling in NSCLC: Insights from Liquid Biopsy
by: C. Ercolani, et al.
Published: (2023-11-01)

Clinical application of liquid biopsy genomic profiling in NSCLC: Asian perspectives
by: Molly S.C. Li, et al.
Published: (2024-03-01)

OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC
by: Yanzhang Hao, et al.
Published: (2014-01-01)

Liquid Biopsy-based Risk Stratification and Intensification of Treatment In EGFR Mutant Advanced NSCLC (L-BRITE)U
by: H. Baskarane, et al.
Published: (2023-11-01)

Liquid biopsy through non-blood fluids: The show must go on
by: Angelo Dipasquale, et al.
Published: (2024-12-01)

Restaurer et transmettre la « magie » des coulisses des livres animés
by: Clémentine Desmond
Published: (2022-10-01)

La comédie de magie espagnole (1840-1930). Le spectaculaire flamboyant
by: Lise Jankovic
Published: (2015-07-01)

REALISM, MAGIE ȘI METAMORFISM ÎN LOSTRIȚA/ REALISM, MAGIC AND METAMORPHISM IN LOSTRIȚA
by: Iuliana PĂUNESCU( VORONEANU)
Published: (2024-11-01)

Tari Woleka: Seni Ritual Magis Masyarakat Marapu Di Sumba Barat
by: S. Hudijono
Published: (2009-01-01)

Clinical Feasibility of NGS Liquid Biopsy Analysis in NSCLC Patients Using Oncomine Precision Assay with Genexus™ Integrated Sequencer
by: S. Buglioni, et al.
Published: (2023-11-01)

Longitudinal genomic profiling using liquid biopsies in metastatic nonsquamous NSCLC following first line immunotherapy
by: Haolun Ding, et al.
Published: (2025-01-01)

Association of seven antibody levels in lung cancer with chemotherapy effect and prognosis in patients with NSCLC
Published: (2024-10-01)

A scoring model based on bacterial lipopolysaccharide-related genes to predict prognosis in NSCLC
by: Nandi Bao, et al.
Published: (2024-11-01)

Danielle Jouanna, Comment connaître l’avenir pour un Grec ancien : religion, magie et science
by: Etienne Pittoni
Published: (2024-10-01)

Circulating Tumor Cells of Non-small Cell Lung Cancer (NSCLC) Patients. A Potential New Liquid Biopsy Biomarker
by: E. Fernández Armúa, et al.
Published: (2023-11-01)

Relationship between PLR and Clinicopathological Characteristics of Patients with Advanced NSCLC and Its Predictive Value for the Efficacy of Chemotherapy and Prognosis
by: Jianming Zhao, et al.
Published: (2022-01-01)

magi: A Package for Inference of Dynamic Systems from Noisy and Sparse Data via Manifold-Constrained Gaussian Processes
by: Samuel W. K. Wong, et al.
Published: (2024-05-01)

NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centers
by: Michela Verzè, et al.
Published: (2024-06-01)

Genetic selection for postweaning growth rate shows no relevant negative impact on reproductive performance in breeding rabbit does
by: P.J. Marín-García, et al.
Published: (2025-01-01)

Quantitative proteomic analysis unveils a critical role of VARS1 in hepatocellular carcinoma aggressiveness through the modulation of MAGI1 expression
by: Natalia Hermán-Sánchez, et al.
Published: (2025-01-01)

Novel class IIb microcins show activity against Gram-negative ESKAPE and plant pathogens
by: Benedikt M Mortzfeld, et al.
Published: (2024-12-01)

Magie des sons et de la prosodie, et apprentissage de la phonétique par la poésie : « Le Pont Mirabeau »
by: Monique Monville-Burston, et al.
Published: (2020-07-01)

The effect size of rs521851 in the intron of MAGI2/S-SCAM on HADS-D scores correlates with EAT-26 scores for eating disorders risk
by: Daria Pinakhina, et al.
Published: (2024-12-01)

Språkens magi. En festskrift för Ingmar Söhrman, professor i romanska språk. Institutionen för språk och litteratur, Göteborgs universitet, 2017
by: Mats Forsgren
Published: (2018-06-01)

Phenotypic diversity of CTCs and tdEVs in liquid biopsies of tumour-draining veins is linked to poor prognosis in colorectal cancer
by: Stefan A. Cieslik, et al.
Published: (2025-01-01)

Elucidating the potential of EGFR mutated NSCLC and identifying its multitargeted inhibitors
by: Anakha D. Rajeeve, et al.
Published: (2025-01-01)

Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family”
by: Andrea Gottardo, et al.
Published: (2024-03-01)

Analysis of Immunoregulatory Genes Expression in PBMCs as Potential Predictive and Prognostic Biomarkers in NSCLC Patients Treated with Immunotherapy
by: A. Moreno Manuel, et al.
Published: (2023-11-01)

Transcriptomic Signatures of Antibody-mediated Rejection in Early Biopsies With Negative Histology in HLA-incompatible Kidney Transplantation
by: Petra Hruba, PhD, et al.
Published: (2025-01-01)

The Chances of Subsequent Cancer Detection in Patients with a PSA > 20 ng/ml and an Initial Negative Biopsy
by: Nadeem Shaida, et al.
Published: (2009-01-01)

Antibiotic Use and Survival in Patients With Late-Stage NSCLC Treated With Chemoimmunotherapy
by: Emanuela Taioli, MD, PhD, et al.
Published: (2024-12-01)

ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB
by: Ornella Franzese, et al.
Published: (2024-12-01)

CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers
by: Francois-Xavier Danlos, et al.
Published: (2022-02-01)

RANK is a poor prognosis marker and a therapeutic target in ER‐negative postmenopausal breast cancer
by: Marina Ciscar, et al.
Published: (2023-03-01)

Biopsy with the New Essen Biopsy Forceps
by: Peter G. Traine, et al.
Published: (2013-01-01)

First-Line Treatment of _ALK_-Positive NSCLC
by: Hasna Bouchaab
Published: (2020-11-01)

What is the Optimal Treatment Duration of Immunotherapy for NSCLC?
by: Sebastian Kraus, et al.
Published: (2024-03-01)

Characterization of the genomic landscape in liver oligometastatic NSCLC
by: Rongxin Liao, et al.
Published: (2025-01-01)